To view this email as a web page, click here

   Home

Subscribe

Advertise

 

 

 

 

June 19, 2019___

Today's Rundown

Featured Story

Gilead taps Nurix's protein degradation tech in $45M cancer pact

Gilead is enlisting Nurix to create new cancer medicines that break down disease-causing proteins. The Big Pharma is handing over $45 million upfront in a deal that could reach $2.3 billion in value if all milestones are met and royalties realized.

Top Stories

Distrust is frustrating U.K. NHS-industry cooperation: report

Britain’s NHS and pharma industry are failing to collaborate effectively, according to a report involving people on both sides. The report cites distrust among the barriers that are limiting the number of effective cross-sector collaborations.

Schrödinger hires ex-Eisai, Merck staff for push into clinic

Schrödinger has hired researchers from Eisai and Merck to support the progress of its wholly owned assets toward the clinic. The news comes weeks after Schrödinger pulled in more cash to fund its evolution into a biotech with an internal pipeline.

Canaan-backed Comet uncloaks with $28.5M and biopharma vet De Graaf at the helm

Comet Therapeutics unveiled itself with $28.5 million in series A financing and biopharma veteran David De Graaf, Ph.D., as its CEO. The capital will carry Comet through 2021, when it plans to move its first program into the clinic.

Qiagen launches one-stop antimicrobial resistance database alongside CDC commitment

In the face of growing international concerns over antimicrobial resistance, Qiagen has launched a one-stop shop that compiles publicly available genomic data, scientific literature and phenotypic information on potential superbugs.

Kymera rolls out new animal data on its lead protein-degradation drug to treat lymphoma

Kymera is presenting new preclinical data on the lead protein-degradation drug in its pipeline, KYM-001, which it’s developing to treat a particularly aggressive subset of B-cell lymphoma. In mice, the drug promoted tumor regression, both on its own and in combination with BTK inhibitor Imbruvica.

Resources

[Whitepaper] The essential guide to managing laboratory samples

This Essential Guide to Managing Laboratory Samples is a three-part piece exploring common problems experienced in the management of samples and how, for any scale of operation, significant efficiency and accuracy benefits can be gained using dedicated sample management software.

[Whitepaper] Satisfying GxP Requirements Using the Internet of Things (IoT)

How can the Internet of Things (IoT) enable you to meet GxP?

[Whitepaper] Managing Comorbidities in Type 2 Diabetes – Real World Evidence for Change

Patients living with diabetes deserve better – Real-World Evidence for effecting/realizing change in the management of type 2 diabetes and cardiovascular/renal comorbidities.

[Webinar] Why do US sponsors come to Russia? New options for clinical trials.

Fast and cost-efficient patient-enrollment,100% success strategy for obtaining a CTA, unified market authorization across the EEU countries. Find out the key compelling reasons to conduct studies in Russia.

[Whitepaper] Agile Competitive Intelligence Strategies For Healthcare

What is agile competitive intelligence, and how can it help take market research to the next level?

[POCKET GUIDE] Reference and Literature Management Made Easy

Get 5 quick tips for faster research and better results!

[Report] Precision medicine from concept to clinic

In this publication, Blue Latitude Health maps the journey of stakeholders impacted by the rise of precision medicine today. Download the report.

[Whitepaper] Flow Chemistry: A Scale-Up Solution for Modern API Development & Manufacturing

Increase Safety & Flexibility with Flow Chemistry

[On-Demand Webinar] Lessons Learned Implementing an End-to-End RIM Solution

IONIS shares best practices for implementing an end-to-end RIM solution in this on-demand webinar. Watch now.

[Whitepaper] Site-specific, Patient-centered and Whip-smart: Enrollment Assistants Adapt to a Shifting Landscape

Increasingly complex clinical trials place a tremendous burden on study sites, exacerbating already-troubling recruitment and enrollment issues. Overwhelmed, many sites may not be up to the task or have the appropriate infrastructure, creating costly delays that keep new therapies from patients.

[Case Study] Clinical Supply Management

Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study.

[Video] Demand Led Services and Clinical Supply Efficiency

Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels.

[eBook] Strategies for Efficient Clinical Supply Management and Forecasting

Download the eBook to explore a proactive approach for clinical supply management.

Events